• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Abiko Kaoru  安彦 郁

ORCIDConnect your ORCID iD *help
… Alternative Names

ABIKO Kaoru  安彦 郁

Less
Researcher Number 20508246
Other IDs
Affiliation (Current) 2025: 独立行政法人国立病院機構(京都医療センター臨床研究センター), 内分泌代謝高血圧研究部, 研究員
2025: 金沢大学, 医学系, 教授
Affiliation (based on the past Project Information) *help 2018 – 2024: 独立行政法人国立病院機構(京都医療センター臨床研究センター), 内分泌代謝高血圧研究部, 研究員
2018: 京都大学, 医学研究科, 助教
2017: 京都大学, 医学(系)研究科(研究院), その他
2013 – 2017: 京都大学, 医学(系)研究科(研究院), 助教
2016: 京都大学, 医学研究科, 助教
2016: 京都大学, 医学研究科, 特定助教
2015: 京都大学, 大学院医学研究科, 准教授
Review Section/Research Field
Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related / Basic Section 50020:Tumor diagnostics and therapeutics-related
Except Principal Investigator
Obstetrics and gynecology / Basic Section 56040:Obstetrics and gynecology-related / Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields / Tumor biology and related fields
Keywords
Principal Investigator
卵巣癌 / MDSC / 遊走 / 免疫治療 / ケモカイン / 抗腫瘍免疫 / リスク低減卵管卵巣摘出術 / マクロファージ / 腫瘍免疫 / 子宮体癌 … More / 子宮頸癌 / 免疫学 / 免疫逃避 / 免疫抑制性細胞 / 上皮間葉転換 / 骨髄由来制御性細胞 / VEGF / 低酸素 / 骨髄由来抑制性細胞 / NF-kB / インターフェロンγ / 腹膜播種 / インターフェロンガンマ / リンパ球 / PD-L1 / 免疫 … More
Except Principal Investigator
卵巣癌 / 腫瘍免疫 / 免疫ゲノミクス / 癌 / 婦人科がん / 免疫学 / 子宮体癌 / がん免疫逃避機構 / 婦人科腫瘍学 / PD-1 / PD-L1 / 卵巣がん / がん免疫逃避 / ゲノム / 卵巣明細胞癌 / 多様性 / 免疫ダイナミクス / 免疫チェックポイント / 免疫ダイナミズム / 婦人科腫瘍 / トランスレーショナルリサ―チ / ゲノム解析 / トランスレーショナルリサーチ / 患者モニタリング / 個別化医療 / 健康関連QOL / 婦人科癌 / アプリケーション / ヘルスケア / ライフログ / 機械学習/人工知能 / デジタルヘルス / PRO / QOL / 甲状腺機能異常合併妊娠 / 臍帯血 / 母児の甲状腺機能 / 新生児の甲状腺機能 / 妊娠期の甲状腺機能 / 潜在性甲状腺機能低下症合併妊娠 / 妊婦の抗甲状腺抗体 / 出生児体重 / 甲状腺機能 / 妊娠 / 出生時体重 / 分娩 / 妊婦 / 潜在性甲状腺機能低下症 / 母子の甲状腺機能 / 免疫逃避 / 腹水濾過濃縮再静注療法(CART) / 癌性腹水 / CARTシステム / CART / がん性腹水 / 網羅的遺伝子発現解析 / 免疫細胞レパトア解析 / 網羅的遺伝子変異解析 / 癌免疫 / PD-L1抗体 / PD-1抗体 / B7ファミリー / 卵巣癌腹膜播種モデル / T細胞解析 / がん免疫機構 / 機能ゲノム解析 / 免疫ゲノミクス解析 / 植物性タンパク質 / 動物性タンパク質 / 食品 / 機能ゲノミクススクリーニング / 腹膜播種 / 癌幹細胞 / 免疫療法 / 機能ゲノミクス / がん免疫抑制 / 腫瘍免疫学 / 医療・福祉 / 免疫チェックポイント阻害薬 / がん免疫療法 / Immuno-genomics / アノイキス抵抗性 / 化学療法感受性 / 分子標的療法 / 抗腫瘍免疫 / バイオマーカー / 卵巣明細胞腺癌 / 上皮間葉転換 / 卵巣漿液性癌 / 個別化 / タキサン / 個別化治療 / 化学療法予測 Less
  • Research Projects

    (17 results)
  • Research Products

    (148 results)
  • Co-Researchers

    (35 People)
  •  卵巣がんの発生初期の免疫微小環境に着目した腹膜播種機構の解明と新規治療法の開発Principal Investigator

    • Principal Investigator
      安彦 郁
    • Project Period (FY)
      2023 – 2025
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Department of Clinical Research, National Hospital Organization Kyoto Medical Center
  •  Novel diagnostic and therapeutic strategies for ovarian cancer by investigation of cancer and host diversity

    • Principal Investigator
      万代 昌紀
    • Project Period (FY)
      2021 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Kyoto University
  •  Identification of chemokine-network causing MDSC migration in ovarian cancer microenvironmentPrincipal Investigator

    • Principal Investigator
      安彦 郁
    • Project Period (FY)
      2020 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Department of Clinical Research, National Hospital Organization Kyoto Medical Center
  •  reration of subclinical hypothyroidism and fetal and maternal complications

    • Principal Investigator
      Wada Michiko
    • Project Period (FY)
      2018 – 2022
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Department of Clinical Research, National Hospital Organization Kyoto Medical Center
  •  Development of patient monitoring methods aimed at developing a comprehensive support program for gynecologic cancer

    • Principal Investigator
      Mandai Masaki
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 56:Surgery related to the biological and sensory functions and related fields
    • Research Institution
      Kyoto University
  •  Investigation of immune-suppressive dynamism and exploratory research for new treatment strategy for gynecologic cancer

    • Principal Investigator
      Hamanishi Junzo
    • Project Period (FY)
      2018 – 2020
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56040:Obstetrics and gynecology-related
    • Research Institution
      Kyoto University
  •  Mechanism of immune-evasion associated with epithelial mesenchymal transition in ovarian cancerPrincipal Investigator

    • Principal Investigator
      Abiko Kaoru
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Department of Clinical Research, National Hospital Organization Kyoto Medical Center
      Kyoto University
  •  Investigation of acquired resistance of PD-1 inhibitor with recycle of CART system

    • Principal Investigator
      Hamanishi Junzo
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Research Field
      Tumor biology and related fields
    • Research Institution
      Kyoto University
  •  The genome analyses for advanced and recurrent ovarian clear cell carcinoma

    • Principal Investigator
      Ikuo Konishi
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  In vivo functional genomics screen reveals mechanism of peritoneal dissemination in ovarian cancer

    • Principal Investigator
      Konishi Ikuo
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  Investigation of the mechanism how dietary foods influence on progression of ovarian cancer.

    • Principal Investigator
      MATSUMURA Noriomi
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kindai University
      Kyoto University
  •  A basic study of a new therapy based on an integrated cancer immune-genomic analysis for ovarian cancer

    • Principal Investigator
      Koshiyama Masafumi
    • Project Period (FY)
      2016 – 2017
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  Mechanism of immune-suppression causing Bevacizumab resistance in ovarian cancerPrincipal Investigator

    • Principal Investigator
      Abiko Kaoru
    • Project Period (FY)
      2015 – 2016
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  Establishment of utilized predictive biomarkers of chemo sensitivity for ovarian cancer patients

    • Principal Investigator
      Konishi Ikuo
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (A)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  Fundamental research of host immune-genomics and development of new cancer therapy for ovarian cancer

    • Principal Investigator
      Hamanishi Junzo
    • Project Period (FY)
      2014 – 2016
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  An exploration of novel immunosuppressive factors by using immunological functional genome screening and development of new treatment strategy in ovarian cancer

    • Principal Investigator
      HAMANISHI Junzo
    • Project Period (FY)
      2014 – 2015
    • Research Category
      Grant-in-Aid for Challenging Exploratory Research
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University
  •  Expression control mechanism and function of immunosuppressive molecule PD-L1 in ovarian cancerPrincipal Investigator

    • Principal Investigator
      ABIKO Kaoru
    • Project Period (FY)
      2013 – 2014
    • Research Category
      Grant-in-Aid for Research Activity Start-up
    • Research Field
      Obstetrics and gynecology
    • Research Institution
      Kyoto University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 Other

All Journal Article Presentation

  • [Journal Article] FSH-producing pituitary neuroendocrine tumor as a cause of ovarian hyperstimulation syndrome2024

    • Author(s)
      Kitamura Takuya、Nanba Kazutaka、Doi Kento、Kishimoto Naoya、Abiko Kaoru、Kuwahara Ryo、Moriyoshi Koki、Inoshita Naoko、Tagami Tetsuya
    • Journal Title

      Endocrinology, Diabetes & Metabolism Case Reports

      Volume: 2024 Issue: 1 Pages: 0119-0119

    • DOI

      10.1530/edm-23-0119

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-23K08859
  • [Journal Article] SLFN11 is a <i>BRCA</i> Independent Biomarker for the Response to Platinum-Based Chemotherapy in High-Grade Serous Ovarian Cancer and Clear Cell Ovarian Carcinoma2023

    • Author(s)
      Akashi Hidehiko、Yachida Nozomi、Ueda Haruka、Yamaguchi Manako、Yamawaki Kaoru、Tamura Ryo、Suda Kazuaki、Ishiguro Tatsuya、Adachi Sosuke、Nagase Yoshikazu、Ueda Yutaka、Ueda Masashi、Abiko Kaoru、Kagabu Masahiro、Baba Tsukasa、Nakaoka Hirofumi、Enomoto Takayuki、Murai Junko、Yoshihara Kosuke
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 23 Issue: 1 Pages: 106-116

    • DOI

      10.1158/1535-7163.mct-23-0257

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-22K09635, KAKENHI-PROJECT-23K08794, KAKENHI-PROJECT-23K08859, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-21K16810, KAKENHI-PROJECT-22H04925, KAKENHI-PROJECT-23K27447, KAKENHI-PROJECT-23K27459
  • [Journal Article] Characteristic of Endometrial Stromal Sarcoma by Algorithm of Potential Biomarkers for Uterine Mesenchymal Tumor2023

    • Author(s)
      Hayashi Takuma、Sano Kenji、Yaegashi Nobuo、Abiko Kaoru、Konishi Ikuo
    • Journal Title

      Current Issues in Molecular Biology

      Volume: 45 Issue: 8 Pages: 6190-6201

    • DOI

      10.3390/cimb45080390

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-19K09840
  • [Journal Article] Treatment With Antitumor Agents Recommended by Cancer Genome Panel for Uterine Leiomyosarcoma2023

    • Author(s)
      Hayashi Takuma、Kishimoto Naoya、Abiko Kaoru、Konishi Ikuo
    • Journal Title

      Journal of Clinical Medicine Research

      Volume: 15 Issue: 10-11 Pages: 461-468

    • DOI

      10.14740/jocmr5052

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-19K09840
  • [Journal Article] B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression2022

    • Author(s)
      Miyamoto T, Murakami R, Hamanishi J, Tanigaki K, Hosoe Y, Mise N, Takamatsu S, Mise Y, Ukita M, Taki M, Yamanoi K, Horikawa N, Abiko K, Yamaguchi K, Baba T, Matsumura N, Mandai M.
    • Journal Title

      Cancer Immunol Res .

      Volume: 10 Issue: 1 Pages: 56-69

    • DOI

      10.1158/2326-6066.cir-21-0407

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-20K18210, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-21J15178, KAKENHI-PROJECT-20K07319, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-20K21665, KAKENHI-PROJECT-20K16431
  • [Journal Article] Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamics2022

    • Author(s)
      Konishi I, Abiko K, Hayashi T, Yamanoi K, Murakami R, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M; Kyoto Study Group for Ovarian Cancer Research.
    • Journal Title

      J Gynecol Oncol

      Volume: 33(5) Issue: 5

    • DOI

      10.3802/jgo.2022.33.e83

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665
  • [Journal Article] Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells.2022

    • Author(s)
      Mise Y, Hamanishi J, Daikoku T, Takamatsu S, Miyamoto T, Taki M, Yamanoi K, Yamaguchi K, Ukita M, Horikawa N, Abiko K, Murakami R, Furutake Y, Hosoe Y, Terakawa J, Kagabu M, Sugai T, Osakabe M, Fujiwara H, Matsumura N, Mandai M, Baba T.
    • Journal Title

      Carcinogenesis

      Volume: na Issue: 7 Pages: 647-658

    • DOI

      10.1093/carcin/bgac032

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-21K09512, KAKENHI-PROJECT-21J15178, KAKENHI-PROJECT-20K07412
  • [Journal Article] Dynamic host immunity and PD-L1/PD-1 blockade efficacy: developments after “IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer”2022

    • Author(s)
      Abiko Kaoru、Hamanishi Junzo、Matsumura Noriomi、Mandai Masaki
    • Journal Title

      British Journal of Cancer

      Volume: 128 Issue: 3 Pages: 461-467

    • DOI

      10.1038/s41416-022-01960-x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21K09541, KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665, KAKENHI-PROJECT-23K21473
  • [Journal Article] CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer2022

    • Author(s)
      Ukita Masayo、Hamanishi Junzo、Yoshitomi Hiroyuki、Yamanoi Koji、Takamatsu Shiro、Ueda Akihiko、Suzuki Haruka、Hosoe Yuko、Furutake Yoko、Taki Mana、Abiko Kaoru、Yamaguchi Ken、Nakai Hidekatsu、Baba Tsukasa、Matsumura Noriomi、Yoshizawa Akihiko、Ueno Hideki、Mandai Masaki
    • Journal Title

      JCI Insight

      Volume: 7 Issue: 12 Pages: 157215-157215

    • DOI

      10.1172/jci.insight.157215

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K09541, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-22K09630, KAKENHI-PROJECT-20K20610, KAKENHI-PROJECT-20K16431, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-20K21665, KAKENHI-PROJECT-20K22810
  • [Journal Article] Tertiary lymphoid structures are associated with favorable survival outcomes in patients with endometrial cancer2021

    • Author(s)
      Qin Meng、Hamanishi Junzo、Ukita Masayo、Yamanoi Koji、Takamatsu Shiro、Abiko Kaoru、Murakami Ryusuke、Miyamoto Taito、Suzuki Haruka、Ueda Akihiko、Hosoe Yuko、Horie Akihito、Yamaguchi Ken、Mandai Masaki
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: online Issue: 6 Pages: 1431-1442

    • DOI

      10.1007/s00262-021-03093-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21J15178, KAKENHI-PROJECT-21K09548, KAKENHI-PROJECT-20K16431
  • [Journal Article] Tumor Immune Microenvironment during Epithelial-Mesenchymal Transition.2021

    • Author(s)
      Taki M, Abiko K, Ukita M, Murakami R, Yamanoi K, Yamaguchi K, Hamanishi J, Baba T, Matsumura N, Mandai M.
    • Journal Title

      Clin Cancer Res

      Volume: - Issue: 17 Pages: 4459-4459

    • DOI

      10.1158/1078-0432.ccr-20-4459

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-20K21665, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-20K16431
  • [Journal Article] Potential Novel Ovarian Cancer Treatment Targeting Myeloid-Derived Suppressor Cells.2021

    • Author(s)
      Abiko K, Hayashi T, Yamaguchi K, Mandai M, Konishi I.
    • Journal Title

      Cancer Invest.

      Volume: 39(4) Pages: 310-314

    • DOI

      10.1080/07357907.2020.1871487

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K09840, KAKENHI-PROJECT-20K16431
  • [Journal Article] UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study2020

    • Author(s)
      Matsuoka Hideki、Murakami Ryusuke、Abiko Kaoru、Yamaguchi Ken、Horie Akihito、Hamanishi Junzo、Baba Tsukasa、Mandai Masaki
    • Journal Title

      BMC Cancer

      Volume: 20 Issue: 1 Pages: 729-729

    • DOI

      10.1186/s12885-020-07225-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-20K18210, KAKENHI-PROJECT-18H02945
  • [Journal Article] Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment.2020

    • Author(s)
      Horikawa N, Abiko K, Matsumura N, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Taki M, Ukita M, Hosoe Y, Koshiyama M, Konishi I, Mandai M.
    • Journal Title

      Br J Cancer.

      Volume: 122(1) Issue: 6 Pages: 778-788

    • DOI

      10.1038/s41416-019-0725-x

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-17H01587, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-17K11275, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-18K16769, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-18K09308
  • [Journal Article] Acquisition of a side population fraction augments malignant phenotype in ovarian cancer.2019

    • Author(s)
      Yamanoi K, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Murakami R, Taki M, Hosoe Y, Murphy SK, Konishi I, Mandai M, Matsumura N.
    • Journal Title

      Sci Rep.

      Volume: 9(1) Issue: 1 Pages: 14215-14215

    • DOI

      10.1038/s41598-019-50794-w

    • NAID

      120006822513

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-17H01587, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-18K16769
  • [Journal Article] The efficacy of secondary cytoreductive surgery for recurrent ovarian, tubal, or peritoneal cancer in Tian-model low-risk patients.2019

    • Author(s)
      So M, Miyamoto T, Murakami R, Abiko K, Hamanishi J, Baba T, Mandai M.
    • Journal Title

      J Gynecol Oncol.

      Volume: Nov;30(6) Issue: 6

    • DOI

      10.3802/jgo.2019.30.e100

    • NAID

      120006894002

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17H01587, KAKENHI-PROJECT-18K16769
  • [Journal Article] Phosphorylation of STAT1 Serine 727 Enhances Platinum Resistance in Uterine Serous Carcinoma.2019

    • Author(s)
      Zeng X, Baba T, Hamanishi J, Matsumura N, Budiman K, Mise Y, Abiko K, Yamaguchi K, Horikawa N, Huntsman DG, Mulati K, Kitamura S, Taki M, Murakami R, Hosoe Y, Mandai M.
    • Journal Title

      Int J Cancer.

      Volume: 145(6) Issue: 6 Pages: 1635-1647

    • DOI

      10.1002/ijc.32501

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-17K19591
  • [Journal Article] Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum‐Resistant Ovarian Cancer2018

    • Author(s)
      Inayama Yoshihide、Hamanishi Junzo、Matsumura Noriomi、Murakami Ryusuke、Abiko Kaoru、Yamaguchi Ken、Baba Tsukasa、Horie Katsuyuki、Konishi Ikuo、Mandai Masaki
    • Journal Title

      The Oncologist

      Volume: 23 Issue: 11 Pages: 1382-1384

    • DOI

      10.1634/theoncologist.2018-0167

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-18K09308, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-16H05477, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-18H02947
  • [Journal Article] Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation2018

    • Author(s)
      Mana Taki, Kaoru Abiko, Tsukasa Baba, Junzo Hamanishi, et al.
    • Journal Title

      Nature Communications

      Volume: 印刷中

    • NAID

      120006462510

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Journal Article] Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation.2018

    • Author(s)
      Taki M, Abiko K, Baba T, Hamanishi J, Yamaguchi K, Murakami R, Yamanoi K, Horikawa N, Hosoe Y, Nakamura E, Sugiyama A, Mandai M, Konishi I, Matsumura N.
    • Journal Title

      Nature communications

      Volume: Apr 27;9(1) Issue: 1 Pages: 1685-1685

    • DOI

      10.1038/s41467-018-03966-7

    • NAID

      120006462510

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H01587, KAKENHI-PROJECT-17K11275, KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-18K09308, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-18H02947
  • [Journal Article] Mucinous adenocarcinoma, gastric type of the uterine cervix: clinical features and HER2 amplification2018

    • Author(s)
      Nakamura Ayano、Yamaguchi Ken、Minamiguchi Sachiko、Murakami Ryusuke、Abiko Kaoru、Hamanishi Junzo、Kondoh Eiji、Baba Tsukasa、Mandai Masaki、Matsumura Noriomi
    • Journal Title

      Medical Molecular Morphology

      Volume: 52 Issue: 1 Pages: 52-59

    • DOI

      10.1007/s00795-018-0202-2

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09308, KAKENHI-PROJECT-18H02945
  • [Journal Article] VISTA expressed in tumour cells regulates T cell function2018

    • Author(s)
      Mulati Kumuluzi、Hamanishi Junzo、Matsumura Noriomi、Chamoto Kenji、Mise Nathan、Abiko Kaoru、Baba Tsukasa、Yamaguchi Ken、Horikawa Naoki、Murakami Ryusuke、Taki Mana、Budiman Kharma、Zeng Xiang、Hosoe Yuko、Azuma Miyuki、Konishi Ikuo、Mandai Masaki
    • Journal Title

      British Journal of Cancer

      Volume: 120 Issue: 1 Pages: 115-127

    • DOI

      10.1038/s41416-018-0313-5

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18K09287, KAKENHI-PROJECT-18K09308, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-17H01587, KAKENHI-PROJECT-16H05477, KAKENHI-PROJECT-18H02945, KAKENHI-PROJECT-18H02947, KAKENHI-PROJECT-18H04066, KAKENHI-PROJECT-18K16769, KAKENHI-PROJECT-16H06149, KAKENHI-PROJECT-17K19593
  • [Journal Article] Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum.2017

    • Author(s)
      Ohsuga T, Yamaguchi K, Kido A, Murakami R, Abiko K, Hamanishi J, Kondoh E, Baba T, Konishi I, Matsumura N.
    • Journal Title

      BMC Cancer

      Volume: 17 Issue: 1 Pages: 580-580

    • DOI

      10.1186/s12885-017-3573-1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Journal Article] Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells.2017

    • Author(s)
      Horikawa N, Abiko K, Matsumura N, Hamanishi J, Baba T, Yamaguchi K, Yoshioka Y, Koshiyama M, Konishi I.
    • Journal Title

      Clin Cancer Res.

      Volume: Jan 15;23(2) Issue: 2 Pages: 587-599

    • DOI

      10.1158/1078-0432.ccr-16-0387

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-15H04309, KAKENHI-PROJECT-16K15707
  • [Journal Article] Unenhanced region on magnetic resonance imaging represents tumor progression in uterine carcinosarcoma.2017

    • Author(s)
      Inoue A, Yamaguchi K, Kurata Y, Murakami R, Abiko K, Hamanishi J, Kondoh E, Baba T, Kido A, Konishi I, Matsumura N
    • Journal Title

      J Gynecol Oncol

      Volume: 28 Issue: 5

    • DOI

      10.3802/jgo.2017.28.e62

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Journal Article] Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin Therapy.2017

    • Author(s)
      Koshiyama M, Matsumura N, Imai S, Yamanoi K, Abiko K, Yoshioka Y, Yamaguchi K, Hamanishi J, Baba T, Konishi I.
    • Journal Title

      Med Sci Monit.

      Volume: 23 Pages: 826-33

    • DOI

      10.12659/msm.899741

    • NAID

      120005997749

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26462521, KAKENHI-PROJECT-16K15707, KAKENHI-PROJECT-15H04309, KAKENHI-PROJECT-16K15708
  • [Journal Article] Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.2017

    • Author(s)
      Murakami R, Matsumura N, Brown JB, Higasa K, Tsutsumi T, Kamada M, Abou-Taleb H, Hosoe Y, Kitamura S, Yamaguchi K, Abiko K, Hamanishi J, Baba T, Koshiyama M, Okuno Y, Yamada R, Matsuda F, Konishi I, Mandai M.
    • Journal Title

      The American Journal of Pathology

      Volume: 187 Issue: 10 Pages: 2246-2258

    • DOI

      10.1016/j.ajpath.2017.06.012

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17KT0125, KAKENHI-PROJECT-17K19591, KAKENHI-PROJECT-17H01587, KAKENHI-PROJECT-16K15707
  • [Journal Article] Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.2016

    • Author(s)
      Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I.
    • Journal Title

      Int J Clin Oncol.

      Volume: 未

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Journal Article] Two cases of Wolffian tumor with novel magnetic resonance imaging findings reflecting characteristic pathology.2016

    • Author(s)
      Sakai M, Abiko K, Matsumura N, Kondoh E, Yamaguchi K, Minamiguchi S, Kurata Y, Kido A, Konishi I.
    • Journal Title

      J Obstet Gynaecol Res.

      Volume: 42 Issue: 8 Pages: 1046-1051

    • DOI

      10.1111/jog.13020

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Journal Article] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues.2016

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I.
    • Journal Title

      Int J Clin Oncol

      Volume: Jun;21(3) Issue: 3 Pages: 462-73

    • DOI

      10.1007/s10147-016-0959-z

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Journal Article] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues.2016

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I.
    • Journal Title

      Int J Clin Oncol

      Volume: 未

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Journal Article] Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.2016

    • Author(s)
      Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I.
    • Journal Title

      Int J Clin Oncol

      Volume: Jun;21(3) Issue: 3 Pages: 456-61

    • DOI

      10.1007/s10147-016-0968-y

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26293359
  • [Journal Article] Groin lymph node detection and sentinel lymph node biopsy in vulvar cancer.2016

    • Author(s)
      Sakae C, Yamaguchi K, Matsumura N, Nakai H, Yoshioka Y, Kondoh E, Hamanishi J, Abiko K, Koshiyama M, Baba T, Kido A, Mandai M, Konishi I
    • Journal Title

      J Gynecol Oncol.

      Volume: 27 Issue: 6

    • DOI

      10.3802/jgo.2016.27.e57

    • NAID

      120005997862

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Journal Article] Suppression of ABHD2, identified through a functional genomics screen, causes anoikis resistance, chemoresistance and poor prognosis in ovarian cancer.2016

    • Author(s)
      Yamanoi K, Matsumura N, Murphy SK, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Konishi I, Mandai M.
    • Journal Title

      Oncotarget.

      Volume: Jul 26;7(30) Issue: 30 Pages: 47620-47636

    • DOI

      10.18632/oncotarget.9951

    • NAID

      120005820858

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-16K15706, KAKENHI-PROJECT-16K15707
  • [Journal Article] Dual faces of IFN-γ in cancer progression: a role of PD-L1 induction in the determination of pro- and anti-tumor immunity.2016

    • Author(s)
      Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I.
    • Journal Title

      Clin Cancer Res.

      Volume: 未

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] Magnetic resonance imaging findings and prognosis of gastric-type mucinous adenocarcinoma (minimal deviation adenocarcinoma or adenoma malignum) of the uterine corpus: Two case reports.2016

    • Author(s)
      Hino M, Yamaguchi K, Abiko K, Yoshioka Y, Hamanishi J, Kondoh E, Koshiyama M, Baba T, Matsumura N, Minamiguchi S, Kido A, Konishi I.
    • Journal Title

      Mol Clin Oncol.

      Volume: 4 Issue: 5 Pages: 699-704

    • DOI

      10.3892/mco.2016.789

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Journal Article] Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression profiles.2016

    • Author(s)
      Murakami R, Matsumura N, Brown JB, Wang Z, Yamaguchi K, Abiko K, Yoshioka Y, Hamanishi J, Baba T, Koshiyama M, Mandai M, Yamada R, Konishi I.
    • Journal Title

      Gynecol Oncol.

      Volume: 141 Issue: 1 Pages: 49-56

    • DOI

      10.1016/j.ygyno.2016.02.027

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-25462590, KAKENHI-PROJECT-26670722, KAKENHI-PROJECT-26861324, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-25870336, KAKENHI-PROJECT-16K15707
  • [Journal Article] Dual faces of IFN-γ in cancer progression: a role of PD-L1 induction in the determination of pro- and anti-tumor immunity.2016

    • Author(s)
      Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I.
    • Journal Title

      Clin Cancer Res

      Volume: May 15;22(10) Issue: 10 Pages: 2329-34

    • DOI

      10.1158/1078-0432.ccr-16-0224

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26293359
  • [Journal Article] Anti-PD-L1/PD-1 immune therapies in ovarian cancer: basic mechanism and future clinical application.2016

    • Author(s)
      Mandai M, Hamanishi J, Abiko K, Matsumura N, Baba T, Konishi I.
    • Journal Title

      Int J Clin Oncol.

      Volume: 未

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] PD-1/PD-L1 blockade in cancer treatment: perspectives and issues.2016

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I.
    • Journal Title

      Int J Clin Oncol

      Volume: 未

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] Clinical efficacy of neoadjuvant chemotherapy with irinotecan (CPT-11) and nedaplatin followed by radical hysterectomy for locally advanced cervical cancer.2016

    • Author(s)
      Abou-Taleb HA, Koshiyama M, Matsumura N, Baba T, Yamaguchi K, Hamanishi J, Abiko K, Yamanoi K, Murakami R, Horikawa N, Taha AA, Kitamura S, Konishi I.
    • Journal Title

      J Int Med Res.

      Volume: 44 Issue: 2 Pages: 346-356

    • DOI

      10.1177/0300060515591858

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26861324, KAKENHI-PROJECT-26462521, KAKENHI-PROJECT-16K15707
  • [Journal Article] Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.2016

    • Author(s)
      Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I
    • Journal Title

      Am J Pathol.

      Volume: 186 Issue: 5 Pages: 1103-13

    • DOI

      10.1016/j.ajpath.2015.12.029

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K06861, KAKENHI-PROJECT-26861324, KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-15K15598, KAKENHI-PROJECT-16K15707
  • [Journal Article] Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression Subtypes.2016

    • Author(s)
      Murakami R, Matsumura N, Mandai M, Yoshihara K, Tanabe H, Nakai H, Yamanoi K, Abiko K, Yoshioka Y, Hamanishi J, Yamaguchi K, Baba T, Koshiyama M, Enomoto T, Okamoto A, Murphy SK, Mori S, Mikami Y, Minamiguchi S, Konishi I.
    • Journal Title

      Am J Pathol.

      Volume: 未

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Journal Article] Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.2016

    • Author(s)
      Abou-Taleb H, Yamaguchi K, Matsumura N, Murakami R, Nakai H, Higasa K, Amano Y, Abiko K, Yoshioka Y, Hamanishi J, Koshiyama M, Baba T, Yamada R, Matsuda F, Konishi I, Mandai M.
    • Journal Title

      Oncotarget.

      Volume: Aug 23;7(34) Issue: 34 Pages: 54758-54770

    • DOI

      10.18632/oncotarget.10181

    • NAID

      120005820857

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-16K15707
  • [Journal Article] IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer2015

    • Author(s)
      Abiko K, Matsumura N, Hamanishi J, Horikawa N, Murakami R, Yamaguchi K, Yoshioka Y, Baba T, Konishi I, Mandai M
    • Journal Title

      British Journal of Cancer

      Volume: 未確定 Issue: 9 Pages: 1501-1509

    • DOI

      10.1038/bjc.2015.101

    • Peer Reviewed / Acknowledgement Compliant
    • Data Source
      KAKENHI-PROJECT-25893112, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-26670723, KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-25462590, KAKENHI-PROJECT-26670722, KAKENHI-PROJECT-26861324
  • [Journal Article] The BMP signaling pathway leads to enhanced proliferation in serous ovarian cancer-a potential therapeutic target.2015

    • Author(s)
      Peng J, Yoshioka Y, Mandai M, et al
    • Journal Title

      Mol Carcinog

      Volume: Epub ahead of print Issue: 4 Pages: 1-11

    • DOI

      10.1002/mc.22283

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25670703, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-26462521, KAKENHI-PROJECT-26670723, KAKENHI-PROJECT-26861324, KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-25462590, KAKENHI-PROJECT-26670722, KAKENHI-PROJECT-16K15707
  • [Journal Article] Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.2015

    • Author(s)
      Nagura M, Matsumura N, Baba T, Murakami R, Kharma B, Hamanishi J, Yamaguchi K, Abiko K, Koshiyama M, Mandai M, et al.
    • Journal Title

      Gynecol Oncol

      Volume: 136 Issue: 1 Pages: 104-111

    • DOI

      10.1016/j.ygyno.2014.11.075

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-25670703, KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26462521, KAKENHI-PROJECT-26670722, KAKENHI-PROJECT-26670723, KAKENHI-PROJECT-26861324
  • [Journal Article] Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.2015

    • Author(s)
      Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y, Konishi I.
    • Journal Title

      Oncotarget.

      Volume: 6 Pages: 6-6

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.2015

    • Author(s)
      Horikawa N, Baba T, Matsumura N, Murakami R, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Yoshioka Y, Konishi I.
    • Journal Title

      BMC Cancer.

      Volume: 15 Pages: 739-739

    • NAID

      120005749961

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Journal Article] IFN-gamma from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer.2015

    • Author(s)
      Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Naoki Horikawa, Ryusuke Murakami, Ken Yamaguchi, Yumiko Yoshioka, Tsukasa Baba, Ikuo Konishi, Masaki Mandai
    • Journal Title

      Br J Cancer.

      Volume: 印刷中

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Journal Article] Invasion of uterine cervical squamous cell carcinoma cells is facilitated by locoregional interaction with cancer-associated fibroblasts via activating transforming growth factor-beta.2015

    • Author(s)
      Nagura M, Matsumura N, Baba T, Murakami R, Kharma B, Hamanishi J, Yamaguchi K, Abiko K, Koshiyama M, Mandai M, Murata T, Murphy SK, Konishi I.
    • Journal Title

      Gynecol Oncol.

      Volume: 136 Pages: 104-111

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.2015

    • Author(s)
      Horikawa N, Baba T, Matsumura N, Murakami R, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Yoshioka Y, Konishi I.
    • Journal Title

      BMC Cancer.

      Volume: 15 Pages: 739-739

    • NAID

      120005749961

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.2015

    • Author(s)
      Amano Y, Mandai M, Yamaguchi K, Matsumura N, Kharma B, Baba T, Abiko K, Hamanishi J, Yoshioka Y, Konishi I.
    • Journal Title

      Oncotarget.

      Volume: 6 Issue: 28 Pages: 26002-26017

    • DOI

      10.18632/oncotarget.4692

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-25462590, KAKENHI-PROJECT-26670722, KAKENHI-PROJECT-26861324
  • [Journal Article] Safety and Anti-tumor Activity of Anti&#8211;PD-1 Antibody (Nivolumab: ONO-4538/BMS-936558) in Patients with Platinum-resistant Ovarian Cancer.2015

    • Author(s)
      Hamanishi, J., M. Mandai, T. Ikeda, M. Minami, A. Kawaguchi, T. Murayama, M. Kanai, Y. Mori, S. Matsumoto, S. Chikuma, N. Matsumura, K. Abiko, T. Baba, K. Yamaguchi, A. Ueda, Y. Hosoe, S. Morita, M. Yokode, A. Shimizu, T. Honjo, I. Konishi.
    • Journal Title

      J Clin Oncol

      Volume: 33 Issue: 34 Pages: 4015-22

    • DOI

      10.1200/jco.2015.62.3397

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-15K08230, KAKENHI-PROJECT-26460338, KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-25460363, KAKENHI-PROJECT-25462590, KAKENHI-PROJECT-26861324, KAKENHI-PROJECT-25293069, KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-25500003
  • [Journal Article] Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer.2015

    • Author(s)
      Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Murayama T, Kanai M, Mori Y, Matsumoto S, Chikuma S, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Yokode M, Shimizu A, Honjo T, Konishi I.
    • Journal Title

      J Clin Oncol.

      Volume: 33 Pages: 4015-4022

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Journal Article] Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer.2015

    • Author(s)
      Peng J, Hamanishi J, Matsumura N, Abiko K, Murat K, Baba T, Yamaguchi K, Horikawa N, Hosoe Y, Murphy SK, Konishi I, Mandai M.
    • Journal Title

      Cancer Res.

      Volume: 75 Issue: 23 Pages: 5034-5045

    • DOI

      10.1158/0008-5472.can-14-3098

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-25462590, KAKENHI-PROJECT-26670722, KAKENHI-PROJECT-26670723, KAKENHI-PROJECT-26861324, KAKENHI-PROJECT-26293359
  • [Journal Article] Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.2015

    • Author(s)
      Horikawa N, Baba T, Matsumura N, Murakami R, Abiko K, Hamanishi J, Yamaguchi K, Koshiyama M, Yoshioka Y, Konishi I.
    • Journal Title

      BMC Cancer.

      Volume: 15 Issue: 1 Pages: 739-739

    • DOI

      10.1186/s12885-015-1703-1

    • NAID

      120005749961

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-26462521, KAKENHI-PROJECT-26253080, KAKENHI-PROJECT-26861324
  • [Journal Article] Menstrual cyclic change of metastin/GPR54 in endometrium.2015

    • Author(s)
      Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I.
    • Journal Title

      Med Mol Morphol.

      Volume: 未定

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Journal Article] Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix.2014

    • Author(s)
      Nagura M, Koshiyama M, Matsumura N, Kido A, Baba T, Abiko K, Hamanishi J, Yamaguchi K, Mikami Y, Konishi I.
    • Journal Title

      BMC Cancer

      Volume: 14 Issue: 1 Pages: 784-784

    • DOI

      10.1186/1471-2407-14-784

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-26293359, KAKENHI-PROJECT-26462521, KAKENHI-PROJECT-26640076, KAKENHI-PROJECT-26670723, KAKENHI-PROJECT-26861324
  • [Journal Article] 3.Menstrual cyclic change of metastin/GPR54 in endometrium.2014

    • Author(s)
      Baba T, Kang HS, Hosoe Y, Kharma B, Abiko K, Matsumura N, Hamanishi J, Yamaguchi K, Yoshioka Y, Koshiyama M, Mandai M, Murphy SK, Konishi I.
    • Journal Title

      Med Mol Morphol

      Volume: 未定

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Journal Article] Hepatocyte nuclear factor-1β promotes glucose uptake and glycolytic activity in ovarian clear carcinoma2013

    • Author(s)
      T Okamoto, M Mandai, N Matsumura, K Yamaguchi, H Kondoh, Y Amano, T Baba, J Hamanishi, K Abiko, K Kosaka, S K, Murphy, S Mori, I Konishi
    • Journal Title

      Molecular carcinogenesis

      Volume: Sep 17 Issue: 1 Pages: 1-15

    • DOI

      10.1002/mc.22072

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23390186, KAKENHI-PROJECT-24791700, KAKENHI-PROJECT-24791701, KAKENHI-PROJECT-25670350, KAKENHI-PROJECT-25670703, KAKENHI-PROJECT-26253080
  • [Presentation] 免疫チェックポイント阻害薬時代の子宮頸がん治療~手術、放射線、薬物療法から私たちは何を選べばよいのか~2024

    • Author(s)
      安彦郁
    • Organizer
      子宮頸がん治療セミナー
    • Invited
    • Data Source
      KAKENHI-PROJECT-20K16431
  • [Presentation] 免疫チェックポイント阻害薬時代の子宮頸がん治療~治療効果判定と副作用マネジメントを中心に~2023

    • Author(s)
      安彦郁
    • Organizer
      Cervical Cancer Seminar in Hokuriku, 2023年4月、金沢
    • Invited
    • Data Source
      KAKENHI-PROJECT-20K16431
  • [Presentation] 免疫チェックポイント阻害薬時代の子宮頸癌治療~治療効果判定と副作用マネジメントを中心に~」2023

    • Author(s)
      安彦 郁
    • Organizer
      Cervical Cancer Seminar in Hokuriku
    • Invited
    • Data Source
      KAKENHI-PROJECT-20K16431
  • [Presentation] 卵巣癌の抗VEGF抗体獲得耐性の免疫学的機序の解明と克服2021

    • Author(s)
      安彦 郁
    • Organizer
      第62回日本婦人科腫瘍学会学術講演会
    • Invited
    • Data Source
      KAKENHI-PROJECT-20K16431
  • [Presentation] シンポジウム1 腫瘍 免疫チェックポイント阻害薬の次へ~骨髄由来免疫抑制性細胞(MDSC)を標的とした卵巣がん新規治療の開発2020

    • Author(s)
      安彦 郁
    • Organizer
      第72回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-20K16431
  • [Presentation] 免疫チェックポイント阻害薬の次へ 骨髄由来免疫抑制性細胞(MDSC)を標的とした卵巣癌新規治療の開発2020

    • Author(s)
      安彦 郁
    • Organizer
      第72回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] The laparoscopic findings of the mesenchymal transition type of high grade serous ovarian carcinoma is characterized by military intraperitoneal dissemination2019

    • Author(s)
      Ryusuke Murakami Kentaro Ishida, Shunsuke Kawahara, Taito Miyamoto, Miyuki Ito, Kaoru Abiko, Akihito Horie, Junzo Hamanishi, Eiji Kondoh, Tsukasa Baba, Masaki Mandai
    • Organizer
      The 17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2018) 14-16 Sep 2018. Kyoto
    • Data Source
      KAKENHI-PROJECT-17H01587
  • [Presentation] Mechanism of MDSC infiltration in ovarian cancer microenvironment 卵巣癌微小環境におけるMDSC浸潤の機序の解明2019

    • Author(s)
      Kaoru Abiko, Taki Mana, Naoki Horikawa, Junzo Hamanishi, Ken Yamaguchi, Masaki Mandai
    • Organizer
      第78回癌学会腫瘍別シンポジウム 婦人科がんの発生・病態・治療に関する最新の知見
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] CD276 expression on ovarian cancer induces infiltration of myeloid derived suppressor cells2019

    • Author(s)
      Taito Miyamoto, Ryusuke Murakami, Sachiko Kitamura, Naoki Horikawa, Kaoru Abiko, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba and Masaki Mandai
    • Organizer
      第78回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17H01587
  • [Presentation] Bevacizumab maintenance therapy for the histopathological mesenchymal transition type of high-grade serous ovarian carcinoma could well extend the overall survival2019

    • Author(s)
      Kentaro Ishida , Ryusuke Murakami, Akihiko Ueda ,Sachiko Kitamura, Naoki Horikawa, Yoshitsugu Chigusa, Kaoru Abiko, Ken Yamaguchi, Junzo Hamanishi, Masaki Mandai
    • Organizer
      The 7th Biennial Meeting of Asian Society of Gynecologic Oncology
    • Data Source
      KAKENHI-PROJECT-17H01587
  • [Presentation] Passenger fusion genes are novel predictive biomarker of anti-PD-1 antibody nivolumab for ovarian cancer2019

    • Author(s)
      Junzo Hamanishi, Ryusuke Murakami, John B Brown, Tsukasa Baba, Eiji Suzuki, Kaoru Abiko, Masaki Mandai
    • Organizer
      50th Annual Meeting on Women's Cancer (SGO 2019)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02945
  • [Presentation] GM-CSF increases MDSCs infiltration after anti-VEGF therapy in ovarian cancer2019

    • Author(s)
      Kaoru Abiko, Naoki Horikawa, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai
    • Organizer
      SGO2019
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] GM-CSF increases MDSCs infiltration after anti-VEGF therapy in ovarian cancer2019

    • Author(s)
      Kaoru Abiko, Naoki Horikawa, Ryusuke Murakami, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Masaki Mandai
    • Organizer
      SGO Annual Meeting, March 16-19, 2019, Honolulu, HI
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] VISTA in tumor cells regulates T cell function2018

    • Author(s)
      Junzo Hamanishi, Kumuruz Murat, Kenji Chamoto, Nathan Mise, Kaoru Abiko, Tsukasa Baba, Ryusuke Murakami, Miyuki Azuma, Masaki Mandai
    • Organizer
      45th Naito Conference
    • Data Source
      KAKENHI-PROJECT-18H02945
  • [Presentation] Genomic alterations induces metabolic change through the activation of PDK2 in ovarian clear cell carcinoma.2018

    • Author(s)
      Sachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai
    • Organizer
      第70回日本産科婦人科学会学術講演会
    • Data Source
      KAKENHI-PROJECT-17H01587
  • [Presentation] Passenger fusion genes are novel predictive biomarker of anti-PD-1 antibody nivolumab for ovarian cancer.2018

    • Author(s)
      Junzo Hamanishi, Ryusuke Murakami, John B Brown, Tsukasa Baba, Eiji Suzuki, Kaoru Abiko, Masaki Mandai
    • Organizer
      The 50th of American Association for Cancer Research (AACR 2018)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-18H02945
  • [Presentation] Molecular Target Drugs Biomarker Novel Immunotherapy Targeting MDSCs in Ovarian Cancer2018

    • Author(s)
      Kaoru Abiko
    • Organizer
      IGCS2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] VISTA expressed in tumor cells regulates T cell function VISTA expressed in tumor cells regulates T cell function2018

    • Author(s)
      Murat Kumuruz, 濱西 潤三, 松村 謙臣, 茶本 健司, 三瀬 名丹, 安彦 郁, 馬場 長, 山口 建, 村上 隆介, 細江 裕子, 東 みゆき, 小西 郁夫, 万代 昌紀
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-18H02945
  • [Presentation] Snail upregulates CXCL1/2 and induces immune escape through migration of MDSCs in ovarian cancer microenvironment2018

    • Author(s)
      安彦 郁、滝 真奈、堀川直城、水野 林、村上隆介、濱西潤三、馬場 長、万代昌紀
    • Organizer
      日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] HER-2 expression in Gastric type adenocarcinoma of the uterine cervix.2017

    • Author(s)
      Ayano Holmes, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Eiji Kondo, Tsukasa Baba, Noriomi Matsumura
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Place of Presentation
      広島グリーンアリーナ
    • Year and Date
      2017-04-13
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Presentation] Suppression of Warburg effect enhances cisplatin sensitivity in ovarian clear cell carcinoma.2017

    • Author(s)
      Sachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Place of Presentation
      広島グリーンアリーナ
    • Year and Date
      2017-04-13
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Presentation] 卵巣癌における抗VEGF抗体耐性には、GM-CSFを介したMDSCによる免疫抑制が関与する2017

    • Author(s)
      堀川直城、安彦郁、濱西潤三、馬場長、山口建、村上隆介、松村謙臣
    • Organizer
      第5回婦人科がんバイオマーカー研究会学術集会
    • Place of Presentation
      大阪医科大学本部北キャンパス講堂
    • Year and Date
      2017-02-25
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] Specific gene signatures and oligoclonal expansion of B cell repertoire with the responders of anti-PD-1 antibody (Nivolumab) for ovarian cancer; Novel predictive biomarkers.2017

    • Author(s)
      Hamanishi J, Murakami R, Mandai M, Matsumura M, Abiko K, Baba T, Hosoe Y, Yamaguchi K, Konishi I.
    • Organizer
      International Symposium on Immune Diversity and Cancer Therapy Kobe 2017. Hyogo, Japan.
    • Data Source
      KAKENHI-PROJECT-17K19591
  • [Presentation] MDSC浸潤を標的とした卵巣癌新規免疫療法の開発2017

    • Author(s)
      安彦郁、堀川直城、滝真奈、村上隆介、濱西潤三、馬場長 ほか
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K11275
  • [Presentation] Snail inhibits anti-tumor immunity through upregulation of CXCR2 ligands in ovarian cancer.2017

    • Author(s)
      Mana Taki, Kaoru Abiko, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Ryusuke Murakami, Naoki Horikawa, Noriomi Matsumura
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Place of Presentation
      広島グリーンアリーナ
    • Year and Date
      2017-04-13
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Presentation] PDK2 contributes to the platinum resistance of ovarian clear cell carcinoma accompanied by chromosome 17q amplification2017

    • Author(s)
      Sachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura, Masaki Mandai
    • Organizer
      日本癌学会
    • Data Source
      KAKENHI-PROJECT-17H01587
  • [Presentation] The impact of anti-PD-1 antibody Nivolumab on chemo-sensitivity of platinum-resistant recurrent ovarian cancer.2017

    • Author(s)
      Yoshihide Inayama, Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Ryusuke Murakami, Ken Yamaguchi, Tsukasa Baba, Ikuo Konishi
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Place of Presentation
      広島グリーンアリーナ
    • Year and Date
      2017-04-13
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Presentation] The resistance to anti-VEGF therapy in ovarian cancer is mediated through recruitment of hypoxia-induced MDSC.2017

    • Author(s)
      Naoki Horikawa, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi, Noriomi Matsumura
    • Organizer
      第69回日本産科婦人科学会学術講演会
    • Place of Presentation
      広島グリーンアリーナ
    • Year and Date
      2017-04-13
    • Data Source
      KAKENHI-PROJECT-16K15707
  • [Presentation] 卵巣癌における抗VEGF抗体耐性には、低酸素誘導性のMDSC浸潤が関与する2016

    • Author(s)
      堀川直城、安彦郁、濱西潤三、馬場長、山口建、吉岡弓子、小西郁生、松村謙臣
    • Organizer
      第75回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] Identification through a functional genomics screen of factors whose down-regulation enhances the cancer stem cell population in ovarian cancer2016

    • Author(s)
      Koji Yamanoi, Noriomi Matsumura, Kaoru Abiko, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Masafumi Koshiyama, Ikuo Konishi
    • Organizer
      第68回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム(東京都千代田区)
    • Year and Date
      2016-04-21
    • Data Source
      KAKENHI-PROJECT-16K15706
  • [Presentation] 機能的ゲノミクススクリーニングによる、卵巣がんのside population (SP)分画を制御する6遺伝子の同定2016

    • Author(s)
      山ノ井康二、松村謙臣、安彦郁、山口建、濱西潤三、馬場長、越山雅文、小西郁生
    • Organizer
      第75回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2016-10-06
    • Data Source
      KAKENHI-PROJECT-16K15706
  • [Presentation] Specific Gene Signatures and Oligo Clonal Expansion of B cell Repertoire with Responders of Anti-PD-1 Antibody, Nivolumab for Ovarian Cancer; Novel Predictive Biomarkers.2016

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Konishi I.Junzo Hamanishi, Ryusuke Murakami, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Ken Yamaguchi, Tsukasa Baba, Ikuo Konishi;
    • Organizer
      2016 ASCO Annual Meeting
    • Place of Presentation
      USA, Chicago
    • Year and Date
      2016-06-03
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Four pathological subtypes of high-grade serous carcinoma of ovary, fallopian tube and peritoneum show distinct clinical features2016

    • Author(s)
      Takuma Ohsuga, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura and Ikuo Konishi
    • Organizer
      IGCS 15th Biennial Meeting,
    • Place of Presentation
      リスボン
    • Year and Date
      2016-10-29
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] VEGF in ovarian cancer suppresses T cell activity by eliciting Myeloid Derived Suppressor Cells (MDSC) into tumor microenvironment2016

    • Author(s)
      Naoki Horikawa, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi, Noriomi Matsumura
    • Organizer
      16th Biennial meeting of the International Gynecological Cancer Society
    • Place of Presentation
      リスボン
    • Year and Date
      2016-10-29
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Specific gene signatures and oligoclonal expansion of B cell repertoire with the responders of anti-PD-1 antibody (Nivolumab) for ovarian cancer;2016

    • Author(s)
      Hamanishi J. Murakami R, Mandai M, Matsumura N, Abiko K, Baba T, Yamaguchi K, Konishi I.
    • Organizer
      vASCO 2016 (The 52nd Annual Meeting of American Society of Clinical Oncology)
    • Place of Presentation
      Chicago, IL. USA.
    • Year and Date
      2016-06-03
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] The investigation for overcSachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumuraoming platinum resistance of Ovarian Clear Cell Carcinoma with chromosome 17q amplification2016

    • Author(s)
      Sachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, Kaoru Abiko, Junzo Hamanishi, Tsukasa Baba, Noriomi Matsumura
    • Organizer
      がんプロ 5大学連携 香港合同教育セミンター
    • Place of Presentation
      Chinese University HongKong
    • Year and Date
      2016-10-28
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Identification through a functional genomics screen of factors whose down-regulation enhances the cancer stem cell population in ovarian cancer2016

    • Author(s)
      Koji Yamanoi, Noriomi Matsumura, Kaoru Abiko, Ken Yamaguchi, Junzo Hamanishi, Tsukasa Baba, Masafumi Koshiyama, Ikuo Konishi
    • Organizer
      第68回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム、東京
    • Year and Date
      2016-04-21
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Specific gene signatures and oligo-clonal expansion of B cell repertoire with responders of anti-PD-1 antibody (Nivolumab) for ovarian cancer; Novel predictive biomarkers2016

    • Author(s)
      Hamanishi J. Murakami R, Mandai M, Matsumura N, Abiko K, Baba T, Yamaguchi K, Konishi I.
    • Organizer
      The 75th Annual Meeting of Japanese Cancer Association (JCA).
    • Place of Presentation
      Yokohama.
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] 卵巣癌における抗VEGF抗体耐性には、低酸素誘導性のMDSC浸潤が関与する2016

    • Author(s)
      堀川直城、安彦郁、松村謙臣
    • Organizer
      第32回京都がん研究会
    • Place of Presentation
      京都教育文化センター
    • Year and Date
      2016-09-16
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] EMT-related gene Snail inhibits anti-tumor immunity in ovarian cancer through recruitment of MDSC2016

    • Author(s)
      Mana Taki, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Ken Yamaguchi, Masafumi Koshiyama, Yumiko Yoshioka, Naoki Horikawa, Ikuo Konishi
    • Organizer
      第68回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム、東京
    • Year and Date
      2016-04-21
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Integrated analyses of single nucleotide variants and copy number variants by means of exome sequence for ovarian clear cell carcinoma.2016

    • Author(s)
      村上 隆介、松村 謙臣、山口 建、安彦 郁、濱西 潤三、馬場 長、越山 雅文、万代 昌紀、小西 郁生
    • Organizer
      第58回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      米子コンベンションセンター、米子市
    • Year and Date
      2016-07-08
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Inhibition of Snail-induced EMT promotes anti-tumor immune response in ovarian cancer2015

    • Author(s)
      Mana Taki, Kaoru Abiko, Noriomi Matsumura, Tsukasa Baba, Junzo Hamanishi, Naoki Horikawa, Ikuo Konishi
    • Organizer
      An AACR Special Conference on Advances in Ovarian Cancer Research
    • Place of Presentation
      Hyatt Regency Orland(アメリカ合衆国)
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] 卵巣癌の微小免疫環境解析と抗PD-1抗体療法の展望2015

    • Author(s)
      濱西 潤三、万代 昌紀、松村 謙臣、安彦 郁、村上 隆介、馬場 長、山口 建、小西郁生
    • Organizer
      第53回日本癌治療学会学術集会 臓器別シンポジウム
    • Place of Presentation
      国立京都国際会議場
    • Year and Date
      2015-10-30
    • Invited
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] 卵巣癌の微小免疫環境解析と抗PD-1抗体療法の展望2015

    • Author(s)
      濱西 潤三、万代 昌紀、松村 謙臣、安彦 郁、村上 隆介、馬場 長、山口 建、小西郁生
    • Organizer
      第53回日本癌治療学会学術集会 臓器別シンポジウム
    • Place of Presentation
      国立京都国際会館(京都市)
    • Year and Date
      2015-10-30
    • Invited
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Expression of VEGF in ovarian cancer suppresses tumor immunity through recruitment of myeloid derived suppressor cells2015

    • Author(s)
      Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, et al
    • Organizer
      An AACR Special Conference on Advances in Ovarian Cancer Research
    • Place of Presentation
      Orland, Florida, アメリカ合衆国
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] Durable anti-tumor response of Nivolumab (anti-PD-1 antibody) for platinum-resistant ovarian cancer; phase II clinical trial <Scientific Plenary>2015

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Yamaguchi K, Konishi I
    • Organizer
      Annual Meeting on Woman’s Cancer
    • Place of Presentation
      Chicago
    • Year and Date
      2015-03-31
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Survival and Durable Tumor Remission for platinum-resistant Ovarian Cancer receiving Nivolumab (anti-PD-1 antibody).2015

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N. Abiko K, Peng J, Horikawa N, Baba T, Yamaguchi K, Hosoe Y, Konishi I.
    • Organizer
      The 74rd Annual Meeting of Japan Cancer Association, International Session
    • Place of Presentation
      名古屋国際会議場
    • Year and Date
      2015-10-08
    • Invited
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] 卵巣癌におけるVEGF発現と腫瘍免疫の関連2015

    • Author(s)
      堀川直城、安彦郁、松村謙臣、他
    • Organizer
      Gynecology Expert Meeting 2015
    • Place of Presentation
      国立京都国際会館(京都市)
    • Year and Date
      2015-11-20
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] 「抗PD 1 抗体(Nivolumab)を用いた卵巣癌に対する第II 相医師主導治験」2015

    • Author(s)
      濵西潤三、万代昌紀、松村謙臣、安彦郁、馬場長、山口建、植田彰彦、小西郁生
    • Organizer
      第67回 日本産科婦人科学会学術集会 (優秀演題賞受賞講演)
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2015-04-10
    • Invited
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Chemoimmunotherapy with PD-1 blockade and paclitaxel induce a potent antitumor immunity in ovarian cancers.2015

    • Author(s)
      Junzo Hamanishi, Jin Peng, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi, Masaki Mandai
    • Organizer
      An AACR Special Conference on Advances in Ovarian Cancer Research
    • Place of Presentation
      Hyatt Regency Orland(アメリカ合衆国)
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] 卵巣漿液性腺癌におけるVEGF発現と骨髄由来免疫抑制性細胞の検討2015

    • Author(s)
      堀川直城、安彦郁、松村謙臣、他
    • Organizer
      第133回近畿産科婦人科学会学術集会
    • Place of Presentation
      ノボテル甲子園(西宮市)
    • Year and Date
      2015-10-25
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] VEGF expressed in ovarian cancer suppresses tumor immunity through induction of MDSC2015

    • Author(s)
      Naoki Horikawa, Kaoru Abiko, Junzo Hamanishi, et al
    • Organizer
      第74回日本癌学会学術総会
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-08
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] 「抗PD 1 抗体(Nivolumab)を用いた卵巣癌に対する第II 相医師主導治験」2015

    • Author(s)
      濵西潤三、万代昌紀、松村謙臣、安彦郁、馬場長、山口建、植田彰彦、小西郁生
    • Organizer
      第67回 日本産科婦人科学会学術集会 (優秀演題賞受賞講演)
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2015-04-10
    • Invited
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Identification through functional genomics screening of factors whose downregulation enhances the side population in ovarian cancer.2015

    • Author(s)
      Noriomi Matsumura, Koji Yamanoi, Susan K Murphy, Junzo Hamanishi, Kaoru Abiko, Ken Yamaguchi, Tsukasa Baba, Masafumi Koshiyama, Ikuo Konishi
    • Organizer
      An AACR Special Conference on Advances in Ovarian Cancer Research
    • Place of Presentation
      Hyatt Regency Orland(アメリカ合衆国)
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Durable Tumor Remission in Patients with Platinum-Resistant Ovarian Cancer Receiving Nivolumab2015

    • Author(s)
      Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Shimizu A, Honjo T, Konishi I.
    • Organizer
      The 51th Annual meeting of American Society of Clinical Oncology (ASCO)
    • Place of Presentation
      Chicago USA
    • Year and Date
      2015-05-30
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Clinical impact of anti-PD-1 antibody (Nivolumab) for platinum-resistant ovarian cancer; Investigator initiated phase II clinical trial2015

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Yamaguchi K, Baba T, Konishi I
    • Organizer
      The 4th Biennial Meeting of Asian Society of Gynecologic Oncology
    • Place of Presentation
      Seoul, Korea.
    • Year and Date
      2015-11-13
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer2015

    • Author(s)
      Junzo Hamanishi, Masaki Mandai*, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, , Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Toshinori Murayama, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi
    • Organizer
      The 50th Annual meeting of American Society of Clinical Oncology (ASCO) Clinical Science Symposium
    • Place of Presentation
      Chicago USA.
    • Year and Date
      2015-06-01
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Durable Tumor Remission in Patients with Platinum-Resistant Ovarian Cancer Receiving Nivolumab2015

    • Author(s)
      Hamanishi J, Mandai M, Ikeda T, Minami M, Kawaguchi A, Matsumura N, Abiko K, Baba T, Yamaguchi K, Ueda A, Hosoe Y, Morita S, Shimizu A, Honjo T, Konishi I.
    • Organizer
      The 51th Annual meeting of American Society of Clinical Oncology (ASCO)
    • Place of Presentation
      Chicago USA.
    • Year and Date
      2015-05-30
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Expression of VEGF in ovarian cancer suppresses tumor immunity through recruitment of myeloid derived suppressor cells2015

    • Author(s)
      Naoki Horikawa, Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Susan K Murphy, Tsukasa Baba, Ken Yamaguchi, Masafumi Koshiyama, Ikuo Konishi
    • Organizer
      An AACR Special Conference on Advances in Ovarian Cancer Research
    • Place of Presentation
      Hyatt Regency Orland(アメリカ合衆国)
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] Chemoimmunotherapy with PD-1 blockade and paclitaxel induce a potent antitumor immunity in ovarian cancers2015

    • Author(s)
      Hamanishi J, Peng J, Matsumura N. Abiko K, , Baba T, Yamaguchi K, Hosoe Y, Konishi I, Mandai M
    • Organizer
      Advances in Ovarian Cancer Research: Exploiting Vulnerabilities
    • Place of Presentation
      Orlando, USA
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Chemoimmunotherapy with PD-1 blockade and paclitaxel induce a potent antitumor immunity in ovarian cancers2015

    • Author(s)
      Hamanishi J, Peng J, Matsumura N. Abiko K, , Baba T, Yamaguchi K, Hosoe Y, Konishi I, Mandai M,
    • Organizer
      Advances in Ovarian Cancer Research: Exploiting Vulnerabilities
    • Place of Presentation
      Orlando, USA
    • Year and Date
      2015-10-17
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Clinical impact of anti-PD-1 antibody (Nivolumab) for platinum-resistant ovarian cancer; Investigator initiated phase II clinical trial2015

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Yamaguchi K, Baba T, Konishi I
    • Organizer
      The 4th Biennial Meeting of Asian Society of Gynecologic Oncology (Oral presentation)
    • Place of Presentation
      Seoul, Korea
    • Year and Date
      2015-11-13
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] VEGF expressed in ovarian cancer suppresses tumor immunity via recruitment of MDSC2015

    • Author(s)
      Naoki Horikawa, Kaoru Abiko, Junzo, Hamanishi, et al
    • Organizer
      第57回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      アイーナ岩手県民情報センター(盛岡市)
    • Year and Date
      2015-08-07
    • Data Source
      KAKENHI-PROJECT-15K20140
  • [Presentation] “<Scientific Plenary> Durable anti-tumor response of Nivolumab (anti-PD-1 antibody) for platinum-resistant ovarian cancer; phase II clinical trial”2015

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N, Abiko K, Baba T, Yamaguchi K, Konishi I
    • Organizer
      Annual Meeting on Woman’s Cancer.
    • Place of Presentation
      Chicago
    • Year and Date
      2015-03-31
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Survival and Durable Tumor Remission for platinum-resistant Ovarian Cancer receiving Nivolumab (anti-PD-1 antibody).2015

    • Author(s)
      Hamanishi J, Mandai M, Matsumura N. Abiko K, Peng J, Horikawa N, Baba T, Yamaguchi K, Hosoe Y, Konishi I.
    • Organizer
      The 74rd Annual Meeting of Japan Cancer Association, International Session
    • Place of Presentation
      名古屋国際会議場(名古屋市)
    • Year and Date
      2015-10-08
    • Invited
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Immune checkpoint PD-1 signal: the metastatic promotion of ovarian cancer and the target of new treatment strategy2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Jin Peng, Naoki Horikawa, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi
    • Organizer
      The 73rd JCA Symposia(第73回日本癌学会学術集会 シンポジウム)
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2014-09-27
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Immunotherapy with anti-PD-1 antibody (Nivolumab) is promising: Phase II trial for platinum-resistant ovarian cancer2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Jin Peng, Naoki Horikawa, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi
    • Organizer
      第43回日本免疫学会学術集会 The 43rd JSI Workshop
    • Place of Presentation
      京都国際会館
    • Year and Date
      2014-12-11
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] A Phase II Clinical Trial of Immunotherapy with Anti-PD-1 Antibody (Nivolumab) in Advanced/Relapsed, Platinum-resistant Ovarian Cancer2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Jin Peng, Naoki Horikawa, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi
    • Organizer
      15th Biennial Meeting of The International Gynecological Cancer Society
    • Place of Presentation
      Melbourne Australia
    • Year and Date
      2014-11-08
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Immunotherapy with anti-PD-1 antibody (Nivolumab) is promising: Phase II trial for platinum-resistant ovarian cancer2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Jin Peng, Naoki Horikawa, Kumuruz Murat, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi
    • Organizer
      第43回日本免疫学会学術集会 The 43rd JSI Workshop
    • Place of Presentation
      京都国際会館
    • Year and Date
      2014-12-11
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] A Phase II Clinical Trial of Immunotherapy with Anti-PD-1 Antibody (Nivolumab) in Advanced/Relapsed, Platinum-resistant Ovarian Cancer2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Jin Peng, Naoki Horikawa, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi
    • Organizer
      15th Biennial Meeting of The International Gynecological Cancer Society
    • Place of Presentation
      Melbourne Australia
    • Year and Date
      2014-11-08
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] 抗PD-1抗体(Nivolumab)を用いた卵巣癌に対する第II相医師主導治験2014

    • Author(s)
      濵西潤三、万代昌紀、池田隆文、南 学、森由紀子、松本繁巳、竹馬俊介、村山 敏典、松村謙臣、安彦郁、山口建、植田彰彦、森田智視、清水章、本庶佑、小西郁生
    • Organizer
      第52回 日本癌治療学会学術集会 最優秀演題賞受賞講演
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2014-08-29
    • Data Source
      KAKENHI-PROJECT-26670723
  • [Presentation] Immune checkpoint PD-1 signal: the metastatic promotion of ovarian cancer and the target of new treatment strategy2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai, Noriomi Matsumura, Kaoru Abiko, Jin Peng, Naoki Horikawa, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi
    • Organizer
      第73回日本癌学会学術集会 シンポジウム The 73rd JCA Symposia
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2014-09-27
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] Efficacy and safety of anti-PD-1 antibody (Nivolumab: BMS-936558, ONO-4538) in patients with platinum-resistant ovarian cancer2014

    • Author(s)
      Junzo Hamanishi, Masaki Mandai*, Takafumi Ikeda, Manabu Minami, Atsushi Kawaguchi, , Masashi Kanai, Yukiko Mori, Shigemi Matsumoto, Toshinori Murayama, Shunsuke Chikuma, Noriomi Matsumura, Kaoru Abiko, Tsukasa Baba, Ken Yamaguchi, Akihiko Ueda, Satoshi Morita, Masayuki Yokode, Akira Shimizu, Tasuku Honjo, Ikuo Konishi
    • Organizer
      The 50th Annual meeting of American Society of Clinical Oncology (ASCO2014)
    • Place of Presentation
      Chicago
    • Year and Date
      2014-06-01
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] 抗PD-1抗体(Nivolumab)を用いた卵巣癌に対する第II相医師主導治験 (最優秀演題賞受賞講演))2014

    • Author(s)
      濵西潤三、万代昌紀、池田隆文、南 学、森由紀子、松本繁巳、竹馬俊介、村山 敏典、松村謙臣、安彦郁、山口建、植田彰彦、森田智視、清水章、本庶佑、小西郁生
    • Organizer
      第52回 日本癌治療学会学術集会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2014-08-29
    • Data Source
      KAKENHI-PROJECT-26293359
  • [Presentation] 卵巣癌微小環境においてリンパ球の分泌するIFN-γは癌細胞の免疫抑制分子PD-L1発現を規定する2013

    • Author(s)
      安彦 郁
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] "Immune checkpoint PD-1 signal; the metastatic promotion of ovarian cancer and the target of new treatment strategy"

    • Author(s)
      濱西潤三、万代昌紀、松村謙臣、安彦郁、Jin Peng、馬場長、山口建、小西郁生
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Invited
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] 「卵巣癌腹膜播種のPD-L1発現は、間質内のリンパ球が分泌するIFN-γにより誘導される」

    • Author(s)
      安彦郁、松村謙臣、濱西潤三、堀川直城、Jin Peng、村上隆介、山口建、馬場長、小西郁生、万代昌紀
    • Organizer
      第66回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム
    • Year and Date
      2014-04-18 – 2014-04-20
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] 卵巣癌微小環境において間質内リンパ球が分泌するIFN-γは癌細胞のPD-L1発現を規定する

    • Author(s)
      安彦郁、松村謙臣、濱西潤三、堀川直城、村上隆介、馬場長、山口建、小西郁生、万代昌紀
    • Organizer
      第73回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] 卵巣明細胞腺癌におけるSWI/SNF複合体の網羅的遺伝子変異解析

    • Author(s)
      山口 建, Abou-Taleb Hisham, 松村 謙臣, 天野 泰彰, 山ノ井 康二, 村上 隆介, 安彦 郁, 吉岡 弓子, 濱西 潤三, 越山 雅文, 馬場 長, 小西 郁生
    • Organizer
      第67回日本産科婦人科学会学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2015-04-09 – 2015-04-12
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] 抗PD-1抗体(Nivolumab)を用いた卵巣癌に対する第II相医師主導治験

    • Author(s)
      濱西 潤三, 万代 昌紀, 松村 謙臣, 安彦 郁, 馬場 長, 山口 建, 植田 彰彦, 小西 郁生
    • Organizer
      第67回日本産科婦人科学会学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2015-04-09 – 2015-04-12
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] “IFN-γ secreted from lymphocytes induces PD-L1 expression on cancer cells and promotes ovarian cancer progression”

    • Author(s)
      Kaoru Abiko, Noriomi Matsumura, Junzo Hamanishi, Naoki Horikawa, Ryusuke Murakami, Tsukasa Baba, Ken Yamaguchi, Ikuo Konishi, and Masaki Mandai
    • Organizer
      第43回日本免疫学会学術集会
    • Place of Presentation
      京都国際会議場
    • Year and Date
      2014-12-10 – 2014-12-12
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] IFN-gamma from lymphocytes induces PD-L1 expression and facilitates peritoneal dissemination in ovarian cancer

    • Author(s)
      安彦 郁
    • Organizer
      がんプロ第二回国際シンポジウム
    • Place of Presentation
      グランフロント大阪
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] 卵巣癌細胞のanoikis抵抗性を指標とした機能的ゲノミクススクリーニングにより同定されたABHD2の発現低下は,卵巣癌の化学療法耐性をもたらし予後不良因子となる

    • Author(s)
      山ノ井 康二, 松村 謙臣, 安彦 郁, 山口 建, 吉岡 弓子, 濱西 潤三, 馬場 長, 越山 雅文, 小西 郁生
    • Organizer
      第67回日本産科婦人科学会学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2015-04-09 – 2015-04-12
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] 全エクソームシークエンスによる卵巣明細胞腺癌のsingle nucleotide variantsとcopy number variantsの統合解析

    • Author(s)
      村上 隆介, 松村 謙臣, Abou-Taleb Hisham, 濱西 潤三, 安彦 郁, 山口 建, 馬場 長, 越山 雅文, 小西 郁生, 万代 昌紀
    • Organizer
      第67回日本産科婦人科学会学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2015-04-09 – 2015-04-12
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] 卵巣癌腹膜播種のPD-L1は、間質内のリンパ球が分泌するIFN-gammaにより誘導される

    • Author(s)
      安彦 郁
    • Organizer
      第66回日本産科婦人科学会学術講演会
    • Place of Presentation
      東京国際フォーラム
    • Data Source
      KAKENHI-PROJECT-25893112
  • [Presentation] 卵巣癌大網転移巣におけるVEGF発現は腫瘍内MDSC浸潤を介して局所免疫を抑制している

    • Author(s)
      堀川 直城, 安彦 郁, 濱西 潤三, 松村 謙臣, 馬場 長, 山口 建, 越山 雅文, 吉岡 弓子, 小西 郁生
    • Organizer
      第67回日本産科婦人科学会学術講演会
    • Place of Presentation
      パシフィコ横浜
    • Year and Date
      2015-04-09 – 2015-04-12
    • Data Source
      KAKENHI-PROJECT-26253080
  • [Presentation] 「卵巣癌腹膜播種においてIFN-γはPD-L1発現を誘導し、腫瘍を増大させる」

    • Author(s)
      安彦郁、松村謙臣、濱西潤三、堀川直城、村上隆介、山口建、馬場長、吉岡弓子、小西郁生、万代昌紀
    • Organizer
      第56回日本婦人科腫瘍学会学術講演会
    • Place of Presentation
      栃木県総合文化センターー
    • Year and Date
      2014-07-17 – 2014-07-19
    • Data Source
      KAKENHI-PROJECT-25893112
  • 1.  Hamanishi Junzo (80378736)
    # of Collaborated Projects: 10 results
    # of Collaborated Products: 79 results
  • 2.  Konishi Ikuo (90192062)
    # of Collaborated Projects: 7 results
    # of Collaborated Products: 78 results
  • 3.  村上 隆介 (40782363)
    # of Collaborated Projects: 7 results
    # of Collaborated Products: 24 results
  • 4.  MATSUMURA Noriomi (20452336)
    # of Collaborated Projects: 6 results
    # of Collaborated Products: 83 results
  • 5.  山口 建 (20378772)
    # of Collaborated Projects: 4 results
    # of Collaborated Products: 29 results
  • 6.  Mandai Masaki (80283597)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 16 results
  • 7.  Koshiyama Masafumi (50724390)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 8.  森 誠一 (10334814)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 1 results
  • 9.  山田 亮 (50301106)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 10.  馬場 長 (60508240)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 37 results
  • 11.  Brown John (90583188)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 12.  茶本 健司 (50447041)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 2 results
  • 13.  Wada Michiko (80813815)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 14.  岡本 愛光 (20204026)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 15.  松田 文彦 (50212220)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 16.  吉岡 弓子 (10402918)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 2 results
  • 17.  橋本 貢士 (30396642)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 18.  北 誠 (50767415)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 19.  浅原 哲子 (80373512)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 20.  江川 美保 (50600061)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 21.  大石 直也 (40526878)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 22.  山本 洋介 (30583190)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 23.  日笠 幸一郎 (10419583)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 24.  榎本 隆之 (90283754)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 25.  河本 宏 (00343228)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 26.  奥野 恭史 (20283666)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 27.  滝 真奈 (20898077)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 28.  山ノ井 康二 (70868075)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 29.  林 琢磨 (60359726)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 1 results
  • 30.  KONDOH Hiroshi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 31.  MINAMI Manabu
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 32.  岡本 康司
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 33.  横出 正之
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 34.  村上 幸祐
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 35.  吉富 啓之
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi